stage IV laryngeal cancer
Showing 1 - 25 of >10,000
Blood Tests and Questionnaires in Studying Adherence to
Recruiting
- Carcinoma of Unknown Primary
- +30 more
- Biospecimen Collection
- Questionnaire Administration
-
Houston, TexasM D Anderson Cancer Center
Dec 12, 2022
Clinical Stage II HPV-Mediated (p16-pos) Oropharyngeal Carcinoma, Clinical Stage III HPV-Mediated (p16-pos) Oropharyngeal
Not yet recruiting
- Clinical Stage II HPV-Mediated (p16-pos) Oropharyngeal Carcinoma
- +15 more
- Best Practice
- +9 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
Aug 23, 2022
Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV
Recruiting
- Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +28 more
- Cisplatin
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Dec 16, 2022
Squamous Cell Carcinoma of Head and Neck, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma Stage III
Not yet recruiting
- Squamous Cell Carcinoma of Head and Neck
- +11 more
- KEYTRUDA®
- (no location specified)
Nov 17, 2023
Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Hypopharyngeal Squamous Cell
Recruiting
- Head and Neck Squamous Cell Carcinoma
- +23 more
- Biospecimen Collection
- +2 more
-
Los Angeles, California
- +1 more
Jul 7, 2022
Caregiver, Malignant Head and Neck Tumor, Paranasal Sinus Squamous Cell Carcinoma Trial in Winston-Salem (Communication
Completed
- Caregiver
- +37 more
- Communication Intervention
- +5 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Dec 14, 2022
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,
Recruiting
- Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +24 more
- Carboplatin
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
May 18, 2022
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma Trial
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- +14 more
- Biospecimen Collection
- +9 more
- (no location specified)
Oct 10, 2023
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,
Not yet recruiting
- Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +10 more
- Carboplatin
- +9 more
- (no location specified)
Jan 31, 2023
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Recruiting
- Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +26 more
- Biopsy
- +5 more
-
Newark, Delaware
- +52 more
Feb 2, 2023
Head and Neck Carcinoma, Hypopharyngeal Carcinoma, Laryngeal Carcinoma Trial in Philadelphia (Medical Device Usage and
Recruiting
- Head and Neck Carcinoma
- +15 more
- Medical Device Usage and Evaluation
- +5 more
-
Philadelphia, PennsylvaniaThomas Jefferson University Hospital
Jun 8, 2021
Head and Neck Carcinoma of Unknown Primary, Head and Neck Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell
Active, not recruiting
- Head and Neck Carcinoma of Unknown Primary
- +19 more
- Berzosertib
- +3 more
-
Duarte, California
- +18 more
Aug 24, 2022
Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Squamous
Recruiting
- Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
- +50 more
- transoral robotic surgery
- quality of life assessment
-
Columbus, OhioOhio State University Medical Center
Oct 28, 2022
Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell
Active, not recruiting
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +29 more
- Cytology specimen
- Laboratory biomarker analysis
-
Philadelphia, PennsylvaniaThomas Jefferson University
Aug 31, 2021
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,
Recruiting
- Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +21 more
- Atezolizumab
- +8 more
-
Little Rock, Arkansas
- +97 more
Jan 27, 2023
Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell
Terminated
- Stage III Squamous Cell Carcinoma of the Hypopharynx
- +11 more
- cetuximab
- +3 more
-
Newark, New JerseyNew Jersey Medical School
Apr 19, 2021
Laryngeal Squamous Cell Carcinoma, Stage II Laryngeal Cancer AJCC v8, Stage III Laryngeal Cancer AJCC v8 Trial in Houston
Recruiting
- Laryngeal Squamous Cell Carcinoma
- +2 more
- Carboplatin
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Aug 10, 2022
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With
Completed
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +35 more
- PI3K inhibitor BKM120
- cetuximab
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Sep 14, 2021
Laryngeal Cancer Stage II, Laryngeal Cancer Stage III, Carcinoma, Squamous Cell Trial in Amsterdam (radiotherapy, Olaparib)
Active, not recruiting
- Laryngeal Cancer Stage II
- +3 more
- radiotherapy
- Olaparib
-
Amsterdam, NetherlandsThe Netherlands Cancer Institute
Sep 27, 2022
Early-stage Glottic Larynx Cancer Trial in Dallas (CyberKnife Accelerated Hemilarynx Stereotactic Radiotherapy)
Completed
- Early-stage Glottic Larynx Cancer
- CyberKnife Accelerated Hemilarynx Stereotactic Radiotherapy
-
Dallas, TexasUniversity Of Texas Southwestern Medical Center
Jun 27, 2022
Larynx Cancer Stage I, Glottic Carcinoma Trial in Cairo (Hypofractionated single vocal cord irradiation, Whole laryngeal
Recruiting
- Larynx Cancer Stage I
- Glottic Carcinoma
- Hypofractionated single vocal cord irradiation
- Whole laryngeal radiotherapy
-
Cairo, EgyptNational Cancer Institute, Cairo University
Jan 10, 2023
Malignant Female Reproductive System Tumor, Stage III Cervical Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8 Trial in Duarte
Not yet recruiting
- Malignant Female Reproductive System Neoplasm
- +10 more
- Discussion
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 24, 2023
Head and Neck Carcinoma of Unknown Primary, Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced
Recruiting
- Head and Neck Carcinoma of Unknown Primary
- +24 more
- Cisplatin
- +2 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Aug 6, 2022
Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8, Clinical
Not yet recruiting
- Clinical Stage II Esophageal Adenocarcinoma AJCC v8
- +11 more
- Acupressure Therapy
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jun 12, 2023